ivan health semaglutide ada2026 #ada2026 #semaglutide #obesity #cardiometabolichealth #metabolichealth #clinicalresearch #endocrinology #healthcareinnovation #mash #liverhealth #sleepapnea #asthma #hypertension… Wegovy® Semaglutide 1.7 mg /
Description
By week 48, most had reached a plateau, though this plateau occurred at dramatically lower body weights than their starting points

A: Some participants lost up to 30% of their body weight, about 85 pounds, during the trial

IL-6 is an interleukin that is associated with inflammation

We are constantly thinking about what we will have for our next meal, food shopping, collecting recipes, eating 2 or 3 portions of food, eating between meals, having desserts, etc
were created using Adobe Illustrator 2022, GraphPad Prism 10.0, R (v4.2), and BioRender

The medication signals your brain's appetite centers while also affecting gut motility, which is why some people describe a 'heavy' feeling or mild queasiness during the first 12 weeks